Skip to main content
Caplight Logo









Unitec

Unitec

Genevaunige.ch

Overview

Unitec is the technology transfer office of the University of Geneva, which supports the commercialization of research, encourages the creation of spin-offs, and provides proof-of-concept funding through grants.

Portfolio Companies

2

Website

unige.ch

Investments

Unitec investments
CompanyDateStageLead
EpithelixMar 2006SeedCo-investor
FluoSpheraSep 2021GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Unitec based?

Unitec is headquartered in Geneva, Switzerland.

When was Unitec founded?

Founding year information for Unitec is not publicly available.

How many portfolio companies does Unitec have?

Unitec has 2 portfolio companies in Caplight's dataset.

What are some companies in Unitec's portfolio?

Portfolio companies visible on Caplight include Epithelix, FluoSphera.

What was Unitec's most recent investment shown here?

Unitec's most recent investment in this portfolio sample was in FluoSphera in 2021.

What sectors does Unitec focus on?

Unitec focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.

What company stages does Unitec focus on?

Unitec typically invests at the Early stage.

Firmographic Details

HeadquartersGeneva
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?